SCHEMBL5489681

SCHEMBL5489681

[CH2]CC1=CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4335019 0.72
SCHEMBL73137 0.72
SCHEMBL1145905 0.69
SCHEMBL953448 0.67
SCHEMBL8469471 0.65
SCHEMBL73140 0.65
SCHEMBL49179 0.64
SCHEMBL6591779 0.64
SCHEMBL954499 0.62 CXCR3 (0.42)
SCHEMBL12052616 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112305131-B GC-Orbitrap-MS screening and analyzing method for pesticide residues in animal derived food 中国农业科学院农业质量标准与检测技术研究所 2021-09-21 CN claimed
EP-4281066-A2 ARTEMISININ-PROTEASOME INHIBITOR CONJUGATES AND THEIR USE IN THE TREATMENT OF DISEASE Cornell University (US) 2023-11-29 EP disclosed
EP-3935100-B1 NOVEL EXPANDING COPOLYMERS POLYMER COMPETENCE CENTER LEOBEN GMBH (AT) 2023-07-12 EP disclosed
WO-2023008545-A1 HEAT-TREATMENT OIL COMPOSITION 出光興産株式会社 2023-02-02 WO disclosed
WO-2022264951-A1 HEAT-TREATMENT OIL COMPOSITION 出光興産株式会社 2022-12-22 WO disclosed
EP-3935100-A1 NOVEL EXPANDING COPOLYMERS Polymer Competence Center Leoben Gmbh (AT) 2022-01-12 EP disclosed
CN-113508151-A Novel expanded copolymers 聚合物技术中心莱奥本有限责任公司 2021-10-15 CN disclosed
WO-2020182277-A1 NOVEL EXPANDING COPOLYMERS POLYMER COMPETENCE CENTER LEOBEN GMBH (AT) 2020-09-17 WO disclosed
EP-3110810-B1 PYRAZOLE AMIDE DERIVATIVE TEIJIN PHARMA LTD (JP) 2018-05-02 EP disclosed
EP-3110810-A1 PYRAZOLE AMIDE DERIVATIVE Teijin Pharma Limited (JP) 2017-01-04 EP disclosed
EP-0916668-A1 CHEMOKINE RECEPTOR ANTAGONISTS BANYU PHARMACEUTICAL CO., LTD. (JP) 1999-05-19 EP disclosed
US-5750540-A SIDE EFFECT REDUCTION BANYU PHARMACEUTICAL CO., LTD. (JP) 1998-05-12 US disclosed
EP-0823423-A1 1,4-DISUBSTITUTED PIPERIDINE DERIVATIVES BANYU PHARMACEUTICAL CO., LTD. (JP) 1998-02-11 EP disclosed
US-5422356-A Appetite suppression ELI LILLY AND COMPANY (US) 1995-06-06 US disclosed
EP-0287339-B1 Piperidine opioid antagonists LILLY CO ELI (US) 1994-08-17 EP disclosed
US-5319087-A For blocking mu or kappa receptors in brain ELI LILLY AND COMPANY (US) 1994-06-07 US disclosed
US-5064834-A That block mu or kappa receptors in the brain ELI LILLY AND COMPANY (US) 1991-11-12 US disclosed
US-4992450-A Piperidine opioid antagonists ELI LILLY AND COMPANY (US) 1991-02-12 US disclosed
US-4891379-A BLOCKING MU OR KAPPA RECEPTORS KABUSHIKI KAISHA KOBE SEIKOSHO (JP) 1990-01-02 US disclosed
EP-0287339-A2 Piperidine opioid antagonists ELI LILLY AND COMPANY (US) 1988-10-19 EP disclosed